These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26524624)

  • 1. Control of liver glucokinase activity: A potential new target for incretin hormones?
    Francini F; Massa ML; Polo MP; Villagarcía H; Castro MC; Gagliardino JJ
    Peptides; 2015 Dec; 74():57-63. PubMed ID: 26524624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of preventive effects of exendin-4 and des-fluoro-sitagliptin in a murine model of fructose-induced prediabetes.
    Castro MC; Villagarcía HG; Schinella G; Massa ML; Francini F
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159363. PubMed ID: 37429413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VMP1-related autophagy induced by a fructose-rich diet in β-cells: its prevention by incretins.
    Maiztegui B; Boggio V; Román CL; Flores LE; Zotto HD; Ropolo A; Grasso D; Vaccaro MI; Gagliardino JJ
    Clin Sci (Lond); 2017 Apr; 131(8):673-687. PubMed ID: 28188238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of liver glucokinase activity in rats with fructose-induced insulin resistance and impaired glucose and lipid metabolism.
    Francini F; Castro MC; Gagliardino JJ; Massa ML
    Can J Physiol Pharmacol; 2009 Sep; 87(9):702-10. PubMed ID: 19794521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4 reduces glycemia by increasing liver glucokinase activity: an insulin independent effect.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    Pharmacol Rep; 2012; 64(1):140-9. PubMed ID: 22580530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sitagliptin prevents the development of metabolic and hormonal disturbances, increased β-cell apoptosis and liver steatosis induced by a fructose-rich diet in normal rats.
    Maiztegui B; Borelli MI; Madrid VG; Del Zotto H; Raschia MA; Francini F; Massa ML; Flores LE; Rebolledo OR; Gagliardino JJ
    Clin Sci (Lond); 2011 Jan; 120(2):73-80. PubMed ID: 20795946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannitol 1-phosphate mediates an inhibitory effect of mannitol on the activity and the translocation of glucokinase in isolated rat hepatocytes.
    Niculescu L; Van Schaftingen E
    Diabetologia; 1998 Aug; 41(8):947-54. PubMed ID: 9726598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state.
    Arnés L; Moreno P; Nuche-Berenguer B; Valverde I; Villanueva-Peñacarrillo ML
    Regul Pept; 2009 Feb; 153(1-3):88-92. PubMed ID: 18804493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
    Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
    Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.
    Moreno P; Nuche-Berenguer B; Gutiérrez-Rojas I; Acitores A; Sancho V; Valverde I; González N; Villanueva-Peñacarrillo ML
    J Mol Endocrinol; 2012 Feb; 48(1):37-47. PubMed ID: 22065862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: role of oxidative stress.
    Castro MC; Francini F; Gagliardino JJ; Massa ML
    Biochim Biophys Acta; 2014 Mar; 1840(3):1145-51. PubMed ID: 24361606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle.
    Arnés L; González N; Tornero-Esteban P; Sancho V; Acitores A; Valverde I; Delgado E; Villanueva-Peñacarrillo ML
    Int J Mol Med; 2008 Jul; 22(1):127-32. PubMed ID: 18575785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue.
    Sangle GV; Lauffer LM; Grieco A; Trivedi S; Iakoubov R; Brubaker PL
    Endocrinology; 2012 Feb; 153(2):564-73. PubMed ID: 22186413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of hepatic glucose metabolism by translocation of glucokinase between the nucleus and the cytoplasm in hepatocytes.
    Toyoda Y; Tsuchida A; Iwami E; Shironoguchi H; Miwa I
    Horm Metab Res; 2001 Jun; 33(6):329-36. PubMed ID: 11456280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DPP-4 inhibitor linagliptin and the GLP-1 receptor agonist exendin-4 improve endothelium-dependent relaxation of rat mesenteric arteries in the presence of high glucose.
    Salheen SM; Panchapakesan U; Pollock CA; Woodman OL
    Pharmacol Res; 2015 Apr; 94():26-33. PubMed ID: 25697548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes induced by a fructose-rich diet on hepatic metabolism and the antioxidant system.
    Francini F; Castro MC; Schinella G; García ME; Maiztegui B; Raschia MA; Gagliardino JJ; Massa ML
    Life Sci; 2010 Jun; 86(25-26):965-71. PubMed ID: 20470786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructose-induced inflammation, insulin resistance and oxidative stress: A liver pathological triad effectively disrupted by lipoic acid.
    Castro MC; Massa ML; Arbeláez LG; Schinella G; Gagliardino JJ; Francini F
    Life Sci; 2015 Sep; 137():1-6. PubMed ID: 26188590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression.
    Wu C; Okar DA; Stoeckman AK; Peng LJ; Herrera AH; Herrera JE; Towle HC; Lange AJ
    Endocrinology; 2004 Feb; 145(2):650-8. PubMed ID: 14617577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.